Maternal Alcohol Reduction Interventions (MARI), presented by Dr Abi Rose, Reader in Alcohol behaviour on 18th Sep 2024
Overview:
This presentation will give an overview of women’s alcohol use and harm across the life course, discussing how the role of alcohol changes during different life stages. Introducing some work funded by the UK’s National Institute of Health Research; coproducing digital and non-digital public health interventions to support women’s adherence to relevant guidelines during pregnancy and motherhood. Highlighting women’s lived experience of drinking during maternal periods, and the need for individual and system-based approaches to compassionately support women to make informed decisions about their drinking behaviour.
Objectives:
-
Discussing the drivers of women’s alcohol use (e.g., psychological, societal) the webinar will provide an opportunity to discuss similarities and differences across the UK and Australia.
-
Talking about the benefits and challenges of coproducing research will facilitate discussion on how we can improve this aspect of our research, ensuring our outputs (e.g., interventions) are both evidence-based and practically useful to future users.
-
Outlining both individual and system-based approaches, this webinar will enable discussion on how we can be more effective in influencing system-based approaches (which are needed to tackle major issues, such as health inequalities).
Watch the presentation
About the presenter
Dr Abi Rose is an experimental psychologist at Liverpool John Moores University, UK. Her research explores girls’ and women’s alcohol use and wellbeing, investigating the drivers and consequences of drinking across the life course. Abi works with community groups and public advisors, representing a variety of lived experience concerning alcohol use and mental health. Her research informs development of alcohol health policy and evidence-based support which meets the needs of service users. Abi is Co-Lead of the Substance Use and Addictive Behaviour group in LJMU’s Institute of Health Research and sits on the committee of the UK’s Drugs North West network.